OTC Healthcare in Mexico
Euromonitor International's OTC Healthcare in Mexico market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 128 | Publication date: Sep 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Sales of OTC medication grow at a lower pace
Sales of OTC healthcare registered current value growth of just over 4% in 2008, almost five percentage points below the historic period CAGR of approaching 9%. Indeed, the positive growth in 2008 was linked to price increases rather than higher volume sales. Lower sales were reported by almost every company due to a reduction in the purchasing power of the average Mexican consumer. The global financial crisis certainly impacted the Mexican economy resulting in job losses and tightened budgets. Mexicans shifted their consumption towards basic goods and the pharmaceuticals industry was another victim of this phenomenon.
Mexican regulations may cause abrupt changes
Two major events were at the core of discussions in the pharmaceuticals industry in 2008. The first one was the imminent and gradual commercial liberalisation of this industry by means of the elimination of the so-called requisito de planta (plant requirement) which means that it will be possible for a company to export medications to Mexico even if it does not have a manufacturing plant established in the country. The other news relates to the renewal of the registros sanitarios (sanitary registries), which foresees that only two types of medications will exist in the market from February 2010, namely, commercial brands and generics, eliminating the possibility that similares (similar products) will be sold on the market at this time.
Many leading positions threatened by emerging industry giant
The entry of Genomma Lab to various OTC sectors has started to threaten the position of leading brands over the review period. However, this threat has become more serious as the number of products launched by Genomma Lab includes both new names and traditional brands with a revamped image and further expansion throughout all OTC sectors. It is also very difficult for traditional companies to compete directly against Genomma Lab as it bases its success on massive advertising budgets which are beyond the means of most other competitors. All in all, one of the sectors that remains the most fragmented is medicated skin care, while others such as NRT smoking cessation aids, eye care, ear care, adult mouth care and wound treatments show higher concentration levels.
Chained outlets are taking over the distribution of medications
The distribution landscape that has existed for many decades, characterised by the existence of thousands of individually-owned chemists/pharmacies throughout the country, is disappearing in favour of large chains of chemists/pharmacies and parapharmacies/drugstores that are expanding aggressively across the entire Mexican territory. Along with the sale of medications, these new types of outlets seek to provide a wider range of goods and services to potential consumers, such as the collection of remittances, for example, to make them more attractive for commuters to frequent. This expansion is taking place in chains of both chemists/pharmacies such as Farmacias Guadalajara (Corporativo Fragua) and also in-store parapharmacies/drugstores as the number of supermarkets owned by groups such as Wal-Mart de México, Controladora Comercial Mexicana and Organización Soriana increases.
Modest growth ahead
Over the forecast period, it is expected that sales of OTC healthcare will post very modest growth rates, with a constant value CAGR approaching 2%, supported by population growth. Assuming the Rx to OTC switches of salbutamol for the treatment of asthma and sumatriptan for migraine are approved, forecast growth may be more dynamic.
Table of contents
OTC HEALTHCARE IN MEXICO : MARKET INSIGHT
EXECUTIVE SUMMARY
Sales of OTC medication grow at a lower pace
Mexican regulations may cause abrupt changes
Many leading positions threatened by emerging industry giant
Chained outlets are taking over the distribution of medications
Modest growth ahead
KEY TRENDS AND DEVELOPMENTS
Mexican regulation seeking quality and affordability in medications
Mexicans like to self-medicate
The pharmaceutical industry faces cost pressures
Large distributors of medications are expanding throughout Mexico
A giant is making the OTC industry tremble
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - MEXICO
BAYER DE MéXICO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Bayer de México SA de CV: Key Facts
Summary 3 Bayer de México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 4 Bayer de México SA de CV: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 5 Bayer de México SA de CV: Competitive Position 2008
BOEHRINGER INGELHEIM PROMECO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 7 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2008
FARMACIAS SIMILARES SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Farmacias Similares SA de CV: Key Facts
Summary 10 Farmacias Similares SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Farmacias Similares SA de CV: Competitive Position 2008
GENOMMA LAB SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 12 Genomma Lab SA de CV: Key Facts
Summary 13 Genomma Lab SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 Genomma Lab SA de CV: Competitive Position 2008
GLAXOSMITHKLINE PLC - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 15 GlaxoSmithKline México SA de CV: Key Facts
Summary 16 GlaxoSmithKline México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 17 GlaxoSmithKline México SA de CV: Competitive Position 2008
MERCK-MéXICO SA - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Merck-México SA: Key Facts
Summary 19 Merck-México SA: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 20 Merck-México SA: Competitive Position 2008
NOVARTIS FARMACéUTICA SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Novartis Farmacéutica SA de CV: Key Facts
Summary 22 Novartis Farmacéutica SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 23 Novartis Farmacéutica SA de CV: Competitive Position 2008
PFIZER SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 24 Pfizer SA de CV: Key Facts
Summary 25 Pfizer SA de CV: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 26 Pfizer SA de CV: Competitive Position 2008
PROCTER & GAMBLE DE MéXICO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Procter & Gamble de México SA de CV: Key Facts
Summary 28 Procter & Gamble de México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 29 Procter & Gamble de México SA de CV: Competitive Position 2008
WYETH SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 30 Wyeth SA de CV: Key Facts
Summary 31 Wyeth SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 32 Wyeth SA de CV: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 33 Wyeth SA de CV: Competitive Position 2008
ANALGESICS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
Table 40 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 41 Medicated Skin Care Company Shares by Value 2004-2008
Table 42 Medicated Skin Care Brand Shares by Value 2005-2008
Table 43 Acne Treatments Brand Shares by Value 2005-2008
Table 44 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN MEXICO
HEADLINES
TRENDS – VITAMINS
TRENDS – DIETARY SUPPLEMENTS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 49 Folic Acid v Other B Vitamins 2004-2008
Table 50 Dietary Supplements by Positioning 2006-2008
Table 51 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 52 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 53 Vitamins Brand Shares by Value 2005-2008
Table 54 Dietary Supplements Brand Shares by Value 2005-2008
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 57 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 58 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 59 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 60 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 61 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 62 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN MEXICO
SECTOR DATA
Table 65 Sales of Eye Care by Subsector: Value 2003-2008
Table 66 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 67 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 68 Eye Care Company Shares by Value 2004-2008
Table 69 Eye Care Brand Shares by Value 2005-2008
Table 70 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 71 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN MEXICO
SECTOR DATA
Table 72 Sales of Ear Care: Value 2003-2008
Table 73 Sales of Ear Care: % Value Growth 2003-2008
Table 74 Ear Care Company Shares by Value 2004-2008
Table 75 Ear Care Brand Shares by Value 2005-2008
Table 76 Forecast Sales of Ear Care: Value 2008-2013
Table 77 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN MEXICO
HEADLINES
SECTOR DATA
Table 78 Sales of Adult Mouth Care: Value 2003-2008
Table 79 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 80 Adult Mouth Care Company Shares by Value 2004-2008
Table 81 Adult Mouth Care Brand Shares by Value 2005-2008
Table 82 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 83 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN MEXICO
SECTOR DATA
Table 84 Sales of Calming and Sleeping Products: Value 2003-2008
Table 85 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 86 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 87 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 88 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 89 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN MEXICO
SECTOR DATA
Table 90 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 91 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 92 Wound Treatments Company Shares by Value 2004-2008
Table 93 Wound Treatments Brand Shares by Value 2005-2008
Table 94 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 95 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013